Crossmark

Insights into the biology of fibrodysplasia ossificans progressiva using patient-derived induced pluripotent stem cells

Crossref DOI link: https://doi.org/10.1016/j.reth.2019.04.004

Published Print: 2019-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Nakajima, Taiki

Ikeya, Makoto
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development

Japan Science and Technology Agency

Japan Society for the Promotion of Science (26670661)

Japan Society for the Promotion of Science (16K15662)

Japan Society for the Promotion of Science (25293320)

Japan Agency for Medical Research and Development
License Information

Text and Data Mining valid from 2019-12-01

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-04-05
More Information

This article is maintained by: Elsevier

Article Title: Insights into the biology of fibrodysplasia ossificans progressiva using patient-derived induced pluripotent stem cells

Journal Title: Regenerative Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reth.2019.04.004

Content Type: article

Copyright: © 2019 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.